Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

Stock Information for Genelux Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Genelux Corporation

Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Genelux Corporation Announces Proposed Public Offering of Common Stock
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.